<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37113165</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>01</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>27</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2296-2565</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in public health</Title><ISOAbbreviation>Front Public Health</ISOAbbreviation></Journal><ArticleTitle>The role of machine learning in health policies during the COVID-19 pandemic and in long COVID management.</ArticleTitle><Pagination><StartPage>1140353</StartPage><MedlinePgn>1140353</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1140353</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fpubh.2023.1140353</ELocationID><Abstract><AbstractText>The ongoing COVID-19 pandemic is arguably one of the most challenging health crises in modern times. The development of effective strategies to control the spread of SARS-CoV-2 were major goals for governments and policy makers. Mathematical modeling and machine learning emerged as potent tools to guide and optimize the different control measures. This review briefly summarizes the SARS-CoV-2 pandemic evolution during the first 3 years. It details the main public health challenges focusing on the contribution of mathematical modeling to design and guide government action plans and spread mitigation interventions of SARS-CoV-2. Next describes the application of machine learning methods in a series of study cases, including COVID-19 clinical diagnosis, the analysis of epidemiological variables, and drug discovery by protein engineering techniques. Lastly, it explores the use of machine learning tools for investigating long COVID, by identifying patterns and relationships of symptoms, predicting risk indicators, and enabling early evaluation of COVID-19 sequelae.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Sarmiento Var&#xf3;n, Gonz&#xe1;lez-Puelma, Medina-Ortiz, Aldridge, Alvarez-Saravia, Uribe-Paredes and Navarrete.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Sarmiento Var&#xf3;n</LastName><ForeName>Lindybeth</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Centro Asistencial Docente y de Investigaci&#xf3;n, Universidad de Magallanes, Punta Arenas, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Gonz&#xe1;lez-Puelma</LastName><ForeName>Jorge</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Centro Asistencial Docente y de Investigaci&#xf3;n, Universidad de Magallanes, Punta Arenas, Chile.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Escuela de Medicina, Universidad de Magallanes, Punta Arenas, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Medina-Ortiz</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Departamento de Ingenier&#xed;a en Computaci&#xf3;n, Facultad de Ingenier&#xed;a, Universidad de Magallanes, Punta Arenas, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aldridge</LastName><ForeName>Jacqueline</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Departamento de Ingenier&#xed;a en Computaci&#xf3;n, Facultad de Ingenier&#xed;a, Universidad de Magallanes, Punta Arenas, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alvarez-Saravia</LastName><ForeName>Diego</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Centro Asistencial Docente y de Investigaci&#xf3;n, Universidad de Magallanes, Punta Arenas, Chile.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Escuela de Medicina, Universidad de Magallanes, Punta Arenas, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Uribe-Paredes</LastName><ForeName>Roberto</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Departamento de Ingenier&#xed;a en Computaci&#xf3;n, Facultad de Ingenier&#xed;a, Universidad de Magallanes, Punta Arenas, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Navarrete</LastName><ForeName>Marcelo A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Centro Asistencial Docente y de Investigaci&#xf3;n, Universidad de Magallanes, Punta Arenas, Chile.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Escuela de Medicina, Universidad de Magallanes, Punta Arenas, Chile.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Public Health</MedlineTA><NlmUniqueID>101616579</NlmUniqueID><ISSNLinking>2296-2565</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006291" MajorTopicYN="N">Health Policy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="N">Machine Learning</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">machine learning</Keyword><Keyword MajorTopicYN="N">mathematical models</Keyword><Keyword MajorTopicYN="N">public health policies</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>1</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>28</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>28</Day><Hour>2</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>4</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37113165</ArticleId><ArticleId IdType="pmc">PMC10126380</ArticleId><ArticleId IdType="doi">10.3389/fpubh.2023.1140353</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Shankar S, Mohakuda SS, Kumar A, Nazneen P, Yadav AK, Chatterjee K, et al. . Systematic review of predictive mathematical models of COVID-19 epidemic. Med J Armed Forces India. (2021) 77:S385&#x2013;392. 10.1016/j.mjafi.2021.05.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mjafi.2021.05.005</ArticleId><ArticleId IdType="pmc">PMC8313025</ArticleId><ArticleId IdType="pubmed">34334908</ArticleId></ArticleIdList></Reference><Reference><Citation>Contreras S, Medina-Ortiz D, Conca C, Olivera-Nappa &#xc1;. A novel synthetic model of the glucose-insulin system for patient-wise inference of physiological parameters from small-size OGTT data. Front Bioeng Biotechnol. (2020) 8:195. 10.3389/fbioe.2020.00195</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fbioe.2020.00195</ArticleId><ArticleId IdType="pmc">PMC7083079</ArticleId><ArticleId IdType="pubmed">32232039</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y, Yang C, Xu XF, Xu W, Liu SW. Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19. Acta Pharmacol Sin. (2020) 41:1141&#x2013;9. 10.1038/s41401-020-0485-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41401-020-0485-4</ArticleId><ArticleId IdType="pmc">PMC7396720</ArticleId><ArticleId IdType="pubmed">32747721</ArticleId></ArticleIdList></Reference><Reference><Citation>Magazine N, Zhang T, Wu Y, McGee MC, Veggiani G, Huang W. Mutations and evolution of the SARS-CoV-2 spike protein. Viruses. (2022) 14:640. 10.3390/v14030640</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14030640</ArticleId><ArticleId IdType="pmc">PMC8949778</ArticleId><ArticleId IdType="pubmed">35337047</ArticleId></ArticleIdList></Reference><Reference><Citation>Velavan TP, Meyer CG. The COVID-19 epidemic. Trop Med Int Health. (2020) 25:278. 10.1111/tmi.13383</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/tmi.13383</ArticleId><ArticleId IdType="pmc">PMC7169770</ArticleId><ArticleId IdType="pubmed">32052514</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker MG, Wilson N. The covid-19 elimination debate needs correct data. BMJ. (2020) 371. 10.1136/bmj.m3883</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3883</ArticleId><ArticleId IdType="pubmed">33023885</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmdahl I, Buckee C. Wrong but useful&#x2013;what covid-19 epidemiologic models can and cannot tell us. N Engl J Med. (2020) 383:303&#x2013;5. 10.1056/NEJMp2016822</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMp2016822</ArticleId><ArticleId IdType="pubmed">32412711</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z, Harrich D, Li Z, Hu D, Li D. The unique features of SARS-CoV-2 transmission: comparison with SARS-CoV, MERS-CoV and 2009 H1N1 pandemic influenza virus. Rev Med Virol. (2021) 31:e2171. 10.1002/rmv.2171</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2171</ArticleId><ArticleId IdType="pmc">PMC7537046</ArticleId><ArticleId IdType="pubmed">33350025</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Campbell H, Kulkarni D, Harpur A, Nundy M, Wang X, et al. . The temporal association of introducing and lifting non-pharmaceutical interventions with the time-varying reproduction number (R) of SARS-CoV-2: a modelling study across 131 countries. Lancet Infect Dis. (2021) 21:193&#x2013;202. 10.1016/S1473-3099(20)30785-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30785-4</ArticleId><ArticleId IdType="pmc">PMC7581351</ArticleId><ArticleId IdType="pubmed">33729915</ArticleId></ArticleIdList></Reference><Reference><Citation>Brauner JM, Mindermann S, Sharma M, Johnston D, Salvatier J, Gaven&#x10d;iak T, et al. . Inferring the effectiveness of government interventions against COVID-19. Science. (2021) 371:eabd9338. 10.1126/science.abd9338</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abd9338</ArticleId><ArticleId IdType="pmc">PMC7877495</ArticleId><ArticleId IdType="pubmed">33323424</ArticleId></ArticleIdList></Reference><Reference><Citation>Howard J, Huang A, Li Z, Tufekci Z, Zdimal V, van der Westhuizen HM, et al. . An evidence review of face masks against COVID-19. Proc Natl Acad Sci USA. (2021) 118:e2014564118. 10.1073/pnas.2014564118</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2014564118</ArticleId><ArticleId IdType="pmc">PMC7848583</ArticleId><ArticleId IdType="pubmed">33431650</ArticleId></ArticleIdList></Reference><Reference><Citation>Cobey S. Modeling infectious disease dynamics. Science. (2020) 368:713&#x2013;714. 10.1126/science.abb5659</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abb5659</ArticleId><ArticleId IdType="pubmed">32332062</ArticleId></ArticleIdList></Reference><Reference><Citation>Flaxman S, Mishra S, Gandy A, Unwin HJT, Mellan TA, Coupland H, et al. . Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe. Nature. (2020) 584:257&#x2013;61. 10.1038/s41586-020-2405-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2405-7</ArticleId><ArticleId IdType="pubmed">32512579</ArticleId></ArticleIdList></Reference><Reference><Citation>Larremore DB, Wilder B, Lester E, Shehata S, Burke JM, Hay JA, et al. . Test sensitivity is secondary to frequency and turnaround time for COVID-19 screening. Sci Adv. (2021) 7:eabd5393. 10.1126/sciadv.abd5393</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abd5393</ArticleId><ArticleId IdType="pmc">PMC7775777</ArticleId><ArticleId IdType="pubmed">33219112</ArticleId></ArticleIdList></Reference><Reference><Citation>Korber B, Fischer WM, Gnanakaran S, Yoon H, Theiler J, Abfalterer W, et al. . Tracking changes in SARS-CoV-2 spike: evidence that D614G increases infectivity of the COVID-19 virus. Cell. (2020) 182:812&#x2013;27. 10.1016/j.cell.2020.06.043</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.06.043</ArticleId><ArticleId IdType="pmc">PMC7332439</ArticleId><ArticleId IdType="pubmed">32697968</ArticleId></ArticleIdList></Reference><Reference><Citation>Fine PE. Herd immunity: history, theory, practice. Epidemiol Rev. (1993) 15:265&#x2013;302. 10.1093/oxfordjournals.epirev.a036121</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oxfordjournals.epirev.a036121</ArticleId><ArticleId IdType="pubmed">8174658</ArticleId></ArticleIdList></Reference><Reference><Citation>To KKW, Hung IFN, Ip JD, Chu AWH, Chan WM, Tam AR, et al. . Coronavirus disease 2019 (COVID-19) re-infection by a phylogenetically distinct severe acute respiratory syndrome coronavirus 2 strain confirmed by whole genome sequencing. Clin Infect Dis. (2020) 73:e2946&#x2013;51. 10.1093/cid/ciaa1275</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1275</ArticleId><ArticleId IdType="pmc">PMC7499500</ArticleId><ArticleId IdType="pubmed">32840608</ArticleId></ArticleIdList></Reference><Reference><Citation>Saad-Roy CM, Morris SE, Metcalf CJE, Mina MJ, Baker RE, Farrar J, et al. . Epidemiological and evolutionary considerations of SARS-CoV-2 vaccine dosing regimes. Science. (2021) 372:363&#x2013;70. 10.1126/science.abg8663</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abg8663</ArticleId><ArticleId IdType="pmc">PMC8128287</ArticleId><ArticleId IdType="pubmed">33688062</ArticleId></ArticleIdList></Reference><Reference><Citation>Tartof SY, Slezak JM, Fischer H, Hong V, Ackerson BK, Ranasinghe ON, et al. . Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study. Lancet. (2021) 398:1407&#x2013;16. 10.1016/S0140-6736(21)02183-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)02183-8</ArticleId><ArticleId IdType="pmc">PMC8489881</ArticleId><ArticleId IdType="pubmed">34619098</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang P, Hasan MR, Chemaitelly H, Yassine HM, Benslimane FM, Al Khatib HA, et al. . BNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the SARS-CoV-2 Delta variant in Qatar. Nat Med. (2021) 27:2136&#x2013;43. 10.1038/s41591-021-01583-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01583-4</ArticleId><ArticleId IdType="pubmed">34728831</ArticleId></ArticleIdList></Reference><Reference><Citation>Prunas O, Warren JL, Crawford FW, Gazit S, Patalon T, Weinberger DM, et al. . Vaccination with BNT162b2 reduces transmission of SARS-CoV-2 to household contacts in Israel. Science. (2022) 375:1151&#x2013;4. 10.1126/science.abl4292</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abl4292</ArticleId><ArticleId IdType="pmc">PMC9261115</ArticleId><ArticleId IdType="pubmed">35084937</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez-Puelma J, Aldridge J, Montes de Oca M, Pinto M, Uribe-Paredes R, Fern&#xe1;ndez-Goycoolea J, et al. . Mutation in a SARS-CoV-2 haplotype from sub-Antarctic Chile reveals new insights into the Spike&#xe2;&#x102;&#x179;s dynamics. Viruses. (2021) 13:883. 10.3390/v13050883</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13050883</ArticleId><ArticleId IdType="pmc">PMC8151058</ArticleId><ArticleId IdType="pubmed">34064904</ArticleId></ArticleIdList></Reference><Reference><Citation>Acevedo ML, Gaete-Argel A, Alonso-Palomares L, de Oca MM, Bustamante A, Gaggero A, et al. . Differential neutralizing antibody responses elicited by CoronaVac and BNT162b2 against SARS-CoV-2 Lambda in Chile. Nat Microbiol. (2022) 7:524&#x2013;9. 10.1038/s41564-022-01092-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-022-01092-1</ArticleId><ArticleId IdType="pubmed">35365787</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez Bernal J, Andrews N, Gower C, Gallagher E, Simmons R, Thelwall S, et al. . Effectiveness of Covid-19 vaccines against the B. 1.617. 2 (Delta) variant. N Engl J Med. (2021) 385:585&#x2013;94. 10.1056/NEJMoa2108891</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2108891</ArticleId><ArticleId IdType="pmc">PMC8314739</ArticleId><ArticleId IdType="pubmed">34289274</ArticleId></ArticleIdList></Reference><Reference><Citation>Kristiansen H, Gad HH, Eskildsen-Larsen S, Despres P, Hartmann R. The oligoadenylate synthetase family: an ancient protein family with multiple antiviral activities. J Interferon Cytokine Res. (2011) 31:41&#x2013;7. 10.1089/jir.2010.0107</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/jir.2010.0107</ArticleId><ArticleId IdType="pubmed">21142819</ArticleId></ArticleIdList></Reference><Reference><Citation>Pulliam JR, van Schalkwyk C, Govender N, von Gottberg A, Cohen C, Groome MJ, et al. . Increased risk of SARS-CoV-2 reinfection associated with emergence of Omicron in South Africa. Science. (2022) 376:eabn4947.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8995029</ArticleId><ArticleId IdType="pubmed">35289632</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathieu E, Ritchie H, Ortiz-Ospina E, Roser M, Hasell J, Appel C, et al. . A global database of COVID-19 vaccinations. Nat Hum Behav. (2021) 5:947&#x2013;53. 10.1038/s41562-021-01122-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41562-021-01122-8</ArticleId><ArticleId IdType="pubmed">33972767</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasell J. A cross-country database of COVID-19 testing. Sci Data. (2020) 7:345. 10.1038/s41597-020-00688-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41597-020-00688-8</ArticleId><ArticleId IdType="pmc">PMC7545176</ArticleId><ArticleId IdType="pubmed">33033256</ArticleId></ArticleIdList></Reference><Reference><Citation>Khare S, Gurry C, Freitas L, Schultz MB, Bach G, Diallo A, et al. . GISAID&#xe2;&#x102;&#x179;s role in pandemic response. China CDC Weekly. (2021) 3:1049. 10.46234/ccdcw2021.255</Citation><ArticleIdList><ArticleId IdType="doi">10.46234/ccdcw2021.255</ArticleId><ArticleId IdType="pmc">PMC8668406</ArticleId><ArticleId IdType="pubmed">34934514</ArticleId></ArticleIdList></Reference><Reference><Citation>Calafiore GC, Novara C, Possieri C. A modified SIR model for the COVID-19 contagion in Italy. In: 2020 59th IEEE Conference on Decision and Control (CDC). Jeju: IEEE; (2020). p. 3889&#x2013;94.</Citation></Reference><Reference><Citation>Annas S, Pratama MI, Rifandi M, Sanusi W, Side S. Stability analysis and numerical simulation of SEIR model for pandemic COVID-19 spread in Indonesia. Chaos Solitons Fractals. (2020) 139:110072. 10.1016/j.chaos.2020.110072</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chaos.2020.110072</ArticleId><ArticleId IdType="pmc">PMC7345386</ArticleId><ArticleId IdType="pubmed">32834616</ArticleId></ArticleIdList></Reference><Reference><Citation>Contreras S, Villavicencio HA, Medina-Ortiz D, Biron-Lattes JP, Olivera-Nappa &#xc1;. A multi-group SEIRA model for the spread of COVID-19 among heterogeneous populations. Chaos Solitons Fractals. (2020) 136:109925. 10.1016/j.chaos.2020.109925</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chaos.2020.109925</ArticleId><ArticleId IdType="pmc">PMC7247502</ArticleId><ArticleId IdType="pubmed">32501373</ArticleId></ArticleIdList></Reference><Reference><Citation>Contreras S, Biron-Lattes JP, Villavicencio HA, Medina-Ortiz D, Llanovarced-Kawles N, Olivera-Nappa &#xc1;. Statistically-based methodology for revealing real contagion trends and correcting delay-induced errors in the assessment of COVID-19 pandemic. Chaos Solitons Fractals. (2020) 139:110087. 10.1016/j.chaos.2020.110087</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chaos.2020.110087</ArticleId><ArticleId IdType="pmc">PMC7341964</ArticleId><ArticleId IdType="pubmed">32834623</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanchez-Daza A, Medina-Ortiz D, Olivera-Nappa A, Contreras S. COVID-19 modeling under uncertainty: statistical data analysis for unveiling true spreading dynamics and guiding correct epidemiological management. In: Modeling, Control and Drug Development for COVID-19 Outbreak Prevention. Springer:  (2022). p. 245&#x2013;82. Available online at: https://link.springer.com/chapter/10.1007/978-3-030-72834-2_9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-030-72834-2_9</ArticleId></ArticleIdList></Reference><Reference><Citation>Bauer S, Contreras S, Dehning J, Linden M, Iftekhar E, Mohr SB, et al. . Relaxing restrictions at the pace of vaccination increases freedom and guards against further COVID-19 waves. PLoS Comput Biol. (2021) 17:e1009288. 10.1371/journal.pcbi.1009288</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pcbi.1009288</ArticleId><ArticleId IdType="pmc">PMC8412259</ArticleId><ArticleId IdType="pubmed">34473693</ArticleId></ArticleIdList></Reference><Reference><Citation>Contreras S, Dehning J, Mohr SB, Bauer S, Spitzner FP, Priesemann V. Low case numbers enable long-term stable pandemic control without lockdowns. Sci Adv. (2021) 7:eabg2243. 10.1126/sciadv.abg2243</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abg2243</ArticleId><ArticleId IdType="pmc">PMC8500516</ArticleId><ArticleId IdType="pubmed">34623913</ArticleId></ArticleIdList></Reference><Reference><Citation>Contreras S, Priesemann V. Risking further COVID-19 waves despite vaccination. Lancet Infect Dis. (2021) 21:745&#x2013;6. 10.1016/S1473-3099(21)00167-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00167-5</ArticleId><ArticleId IdType="pmc">PMC7972303</ArticleId><ArticleId IdType="pubmed">33743848</ArticleId></ArticleIdList></Reference><Reference><Citation>Or&#xf3;stica KY, Contreras S, Mohr SB, Dehning J, Bauer S, Medina-Ortiz D, et al. . Mutational signatures and transmissibility of SARS-CoV-2 Gamma and Lambda variants. arXiv preprint arXiv:210810018. (2021). 10.48550/arXiv.2108.10018</Citation><ArticleIdList><ArticleId IdType="doi">10.48550/arXiv.2108.10018</ArticleId><ArticleId IdType="pmc">PMC11237036</ArticleId><ArticleId IdType="pubmed">38987406</ArticleId></ArticleIdList></Reference><Reference><Citation>Contreras S, Or&#xf3;stica KY, Daza-Sanchez A, Wagner J, D&#xf6;nges P, Medina-Ortiz D, et al. . Model-based assessment of sampling protocols for infectious disease genomic surveillance. Chaos Solitons Fractals. (2023) 167:113093. 10.1016/j.chaos.2022.113093</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chaos.2022.113093</ArticleId></ArticleIdList></Reference><Reference><Citation>Or&#xf3;stica KY, Contreras S, Sanchez-Daza A, Fernandez J, Priesemann V, Olivera-Nappa &#xc1;. New year, new SARS-CoV-2 variant: resolutions on genomic surveillance protocols to face Omicron. Lancet Regional Health Am. (2022) 7:100203. 10.1016/j.lana.2022.100203</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lana.2022.100203</ArticleId><ArticleId IdType="pmc">PMC8837806</ArticleId><ArticleId IdType="pubmed">35187522</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall VJ, Foulkes S, Saei A, Andrews N, Oguti B, Charlett A, et al. . COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study. Lancet. (2021) 397:1725&#x2013;735. 10.1016/S0140-6736(21)00790-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)00790-X</ArticleId><ArticleId IdType="pmc">PMC8064668</ArticleId><ArticleId IdType="pubmed">33901423</ArticleId></ArticleIdList></Reference><Reference><Citation>Joshi G, Borah P, Thakur S, Sharma P, Mayank, Poduri R. Exploring the COVID-19 vaccine candidates against SARS-CoV-2 and its variants: where do we stand and where do we go? Hum Vaccines Immunotherapeut. (2021) 17:4714&#x2013;40. 10.1080/21645515.2021.1995283</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21645515.2021.1995283</ArticleId><ArticleId IdType="pmc">PMC8726002</ArticleId><ArticleId IdType="pubmed">34856868</ArticleId></ArticleIdList></Reference><Reference><Citation>Forni G, Mantovani A. COVID-19 vaccines: where we stand and challenges ahead. Cell Death Diff. (2021) 28:626&#x2013;39. 10.1038/s41418-020-00720-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41418-020-00720-9</ArticleId><ArticleId IdType="pmc">PMC7818063</ArticleId><ArticleId IdType="pubmed">33479399</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai L, Gao GF. Viral targets for vaccines against COVID-19. Nat Rev Immunol. (2021) 21:73&#x2013;82. 10.1038/s41577-020-00480-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-00480-0</ArticleId><ArticleId IdType="pmc">PMC7747004</ArticleId><ArticleId IdType="pubmed">33340022</ArticleId></ArticleIdList></Reference><Reference><Citation>Rawat K, Kumari P, Saha L. COVID-19 vaccine: a recent update in pipeline vaccines, their design and development strategies. Eur J Pharmacol. (2021) 892:173751. 10.1016/j.ejphar.2020.173751</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejphar.2020.173751</ArticleId><ArticleId IdType="pmc">PMC7685956</ArticleId><ArticleId IdType="pubmed">33245898</ArticleId></ArticleIdList></Reference><Reference><Citation>Kyriakidis NC, L&#xf3;pez-Cort&#xe9;s A, Gonz&#xe1;lez EV, Grimaldos AB, Prado EO. SARS-CoV-2 vaccines strategies: a comprehensive review of phase 3 candidates. npj Vaccines. (2021) 6:28. 10.1038/s41541-021-00292-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41541-021-00292-w</ArticleId><ArticleId IdType="pmc">PMC7900244</ArticleId><ArticleId IdType="pubmed">33619260</ArticleId></ArticleIdList></Reference><Reference><Citation>Baden L, El Sahly H, Essink B, et al. . U&#x10d;inkovitost in varnost cepiva mRNA-1273 SARS-CoV-2. N Engl J Med. (2021) 384:403&#x2013;416. 10.1056/NEJMoa2035389</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2035389</ArticleId><ArticleId IdType="pmc">PMC7787219</ArticleId><ArticleId IdType="pubmed">33378609</ArticleId></ArticleIdList></Reference><Reference><Citation>Sa M, Bukhari IA, Akram J, Meo AS, Klonoff DC. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BionTech and Moderna Vaccines. Eur Rev Med Pharmacol Sci. (2021) 25:1663&#x2013;9. 10.26355/eurrev_202102_24877</Citation><ArticleIdList><ArticleId IdType="doi">10.26355/eurrev_202102_24877</ArticleId><ArticleId IdType="pubmed">33629336</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein NP, Lewis N, Goddard K, Fireman B, Zerbo O, Hanson KE, et al. . Surveillance for adverse events after COVID-19 mRNA vaccination. JAMA. (2021) 326:1390&#x2013;9. 10.1001/jama.2021.15072</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.15072</ArticleId><ArticleId IdType="pmc">PMC8511971</ArticleId><ArticleId IdType="pubmed">34477808</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimabukuro T. Allergic reactions including anaphylaxis after receipt of the first dose of Pfizer-BioNTech COVID-19 vaccine&#x2013;United States, December 14-23, 2020. Am J Transpl. (2021) 21:1332. 10.1111/ajt.16516</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ajt.16516</ArticleId><ArticleId IdType="pmc">PMC8013489</ArticleId><ArticleId IdType="pubmed">33641264</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedensohn L, Levin D, Fadlon-Derai M, Gershovitz L, Fink N, Glassberg E, et al. . Myocarditis following a third BNT162b2 vaccination dose in military recruits in Israel. JAMA. (2022) 327:1611&#x2013;2. 10.1001/jama.2022.4425</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.4425</ArticleId><ArticleId IdType="pmc">PMC8931670</ArticleId><ArticleId IdType="pubmed">35297962</ArticleId></ArticleIdList></Reference><Reference><Citation>See I, Su JR, Lale A, Woo EJ, Guh AY, Shimabukuro TT, et al. . US case reports of cerebral venous sinus thrombosis with thrombocytopenia after Ad26. COV2. S vaccination, March 2 to April 21, 2021. JAMA. (2021) 325:2448&#x2013;56. 10.1001/jama.2021.7517</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.7517</ArticleId><ArticleId IdType="pmc">PMC8087975</ArticleId><ArticleId IdType="pubmed">33929487</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanson KE, Goddard K, Lewis N, Fireman B, Myers TR, Bakshi N, et al. . Incidence of Guillain-Barr&#xe9; syndrome after COVID-19 vaccination in the vaccine safety datalink. JAMA Network Open. (2022) 5:e228879-e228879. 10.1001/jamanetworkopen.2022.8879</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.8879</ArticleId><ArticleId IdType="pmc">PMC9044108</ArticleId><ArticleId IdType="pubmed">35471572</ArticleId></ArticleIdList></Reference><Reference><Citation>Grome HN, Threlkeld M, Threlkeld S, Newman C, Martines RB, Reagan-Steiner S, et al. . Fatal multisystem inflammatory syndrome in adult after SARS-CoV-2 natural infection and COVID-19 vaccination. Emerg Infect Dis. (2021) 27:2914. 10.3201/eid2711.211612</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2711.211612</ArticleId><ArticleId IdType="pmc">PMC8544993</ArticleId><ArticleId IdType="pubmed">34586059</ArticleId></ArticleIdList></Reference><Reference><Citation>Miao G, Chen Z, Cao H, Wu W, Chu X, Liu H, et al. . From immunogen to COVID-19 vaccines: prospects for the post-pandemic era. Biomed Pharmacother. (2023) 2023:114208. 10.1016/j.biopha.2022.114208</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2022.114208</ArticleId><ArticleId IdType="pmc">PMC9805901</ArticleId><ArticleId IdType="pubmed">36800265</ArticleId></ArticleIdList></Reference><Reference><Citation>Castanares-Zapatero D, Chalon P, Kohn L, Dauvrin M, Detollenaere J, Maertens de Noordhout C, et al. . Pathophysiology and mechanism of long COVID: a comprehensive review. Ann Med. (2022) 54:1473&#x2013;87. 10.1080/07853890.2022.2076901</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07853890.2022.2076901</ArticleId><ArticleId IdType="pmc">PMC9132392</ArticleId><ArticleId IdType="pubmed">35594336</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV, Group WCCDW, et al. . A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. (2021) 22:e102&#x2013;7. 10.1016/S1473-3099(21)00703-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, et al. . Attributes and predictors of long COVID. Nat Med. (2021) 27:626&#x2013;31. 10.1038/s41591-021-01292-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Boix V, Merino E. Post-COVID syndrome. The never ending challenge. Med Clin. (2022) 158:178. 10.1016/j.medcle.2021.10.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medcle.2021.10.005</ArticleId><ArticleId IdType="pmc">PMC8801902</ArticleId><ArticleId IdType="pubmed">35128063</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong SJ, Liu S. Proposed subtypes of post-COVID-19 syndrome (or long-COVID) and their respective potential therapies. Rev Med Virol. (2022) 32:e2315. 10.1002/rmv.2315</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2315</ArticleId><ArticleId IdType="pubmed">34888989</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de Las-Pe nas C, Notarte KI, Peligro PJ, Velasco JV, Ocampo MJ, Henry BM, et al. . Long-COVID symptoms in individuals infected with different SARS-CoV-2 variants of concern: a systematic review of the literature. Viruses. (2022) 14:2629. 10.3390/v14122629</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14122629</ArticleId><ArticleId IdType="pmc">PMC9785120</ArticleId><ArticleId IdType="pubmed">36560633</ArticleId></ArticleIdList></Reference><Reference><Citation>Stavem K, Ghanima W, Olsen MK, Gilboe HM, Einvik G. Persistent symptoms 1.5-6 months after COVID-19 in non-hospitalised subjects: a population-based cohort study. Thorax. (2021) 76:405&#x2013;7. 10.1136/thoraxjnl-2020-216377</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-216377</ArticleId><ArticleId IdType="pmc">PMC7716295</ArticleId><ArticleId IdType="pubmed">33273028</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y, Yuan D, Chen DG, Ng RH, Wang K, Choi J, et al. . Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. (2022) 185:881&#x2013;95. 10.1016/j.cell.2022.01.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F. Against COVID-19. Post-Acute Care Study Group: for the Gemelli Against CCOVID-19 Post-Acute Care Study Group. Persistent symptoms in patients after acute COVID-19. JAMA. (2020) 9:603. 10.1001/jama.2020.12603</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Dennis A, Wamil M, Alberts J, Oben J, Cuthbertson DJ, Wootton D, et al. . Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study. BMJ Open. (2021) 11:e048391. 10.1136/bmjopen-2020-048391</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-048391</ArticleId><ArticleId IdType="pmc">PMC8727683</ArticleId><ArticleId IdType="pubmed">33785495</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanne JH. Covid-19: even mild infections can cause long term heart problems, large study finds. Br Med J. (2022) 2022:378. 10.1136/bmj.o378</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.o378</ArticleId><ArticleId IdType="pubmed">35165093</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin W, Chen S, Zhang Y, Dong F, Zhang Z, Hu B, et al. . Diffusion capacity abnormalities for carbon monoxide in patients with COVID-19 at 3-month follow-up. Eur Respir J. (2021) 58:2003677. 10.1183/13993003.03677-2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.03677-2020</ArticleId><ArticleId IdType="pmc">PMC7877322</ArticleId><ArticleId IdType="pubmed">33574077</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun B, Tang N, Peluso MJ, Iyer NS, Torres L, Donatelli JL, et al. . Characterization and biomarker analyses of post-COVID-19 complications and neurological manifestations. Cells. (2021) 10:386. 10.3390/cells10020386</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10020386</ArticleId><ArticleId IdType="pmc">PMC7918597</ArticleId><ArticleId IdType="pubmed">33668514</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamers MM, Beumer J, Van Der Vaart J, Knoops K, Puschhof J, Breugem TI, et al. . SARS-CoV-2 productively infects human gut enterocytes. Science. (2020) 369:50&#x2013;4. 10.1126/science.abc1669</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abc1669</ArticleId><ArticleId IdType="pmc">PMC7199907</ArticleId><ArticleId IdType="pubmed">32358202</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhattacharyya A, Seth A, Rai S. The effects of long COVID-19, its severity, and the need for immediate attention: analysis of clinical trials and Twitter data. medRxiv. (2022) 2022&#x2013;09. 10.1101/2022.09.13.22279833</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.09.13.22279833</ArticleId><ArticleId IdType="pmc">PMC9797990</ArticleId><ArticleId IdType="pubmed">36588926</ArticleId></ArticleIdList></Reference><Reference><Citation>Haendel MA, Chute CG, Bennett TD, Eichmann DA, Guinney J, Kibbe WA, et al. . The National COVID Cohort Collaborative (N3C): rationale, design, infrastructure, and deployment. J Am Med Inform Assoc. (2021) 28:427&#x2013;43. 10.1093/jamia/ocaa196</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocaa196</ArticleId><ArticleId IdType="pmc">PMC7454687</ArticleId><ArticleId IdType="pubmed">32805036</ArticleId></ArticleIdList></Reference><Reference><Citation>Alyasseri ZAA, Al-Betar MA, Doush IA, Awadallah MA, Abasi AK, Makhadmeh SN, et al. . Review on COVID-19 diagnosis models based on machine learning and deep learning approaches. Expert Syst. (2022) 39:e12759. 10.1111/exsy.12759</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/exsy.12759</ArticleId><ArticleId IdType="pmc">PMC8420483</ArticleId><ArticleId IdType="pubmed">34511689</ArticleId></ArticleIdList></Reference><Reference><Citation>de F&#xe1;tima Cobre A, Surek M, Stremel DP, Fachi MM, Borba HHL, Tonin FS, et al. . Diagnosis and prognosis of COVID-19 employing analysis of patients' plasma and serum via LC-MS and machine learning. Comput Biol Med. (2022) 146:105659. 10.1016/j.compbiomed.2022.105659</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.compbiomed.2022.105659</ArticleId><ArticleId IdType="pmc">PMC9123826</ArticleId><ArticleId IdType="pubmed">35751188</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolozsv&#xe1;ri LR, B&#xe9;rczes T, Hajdu A, Gesztelyi R, Tiba A, Varga I, et al. . Predicting the epidemic curve of the coronavirus (SARS-CoV-2) disease (COVID-19) using artificial intelligence: an application on the first and second waves. Inform Med Unlocked. (2021) 25:100691. 10.1016/j.imu.2021.100691</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imu.2021.100691</ArticleId><ArticleId IdType="pmc">PMC8349399</ArticleId><ArticleId IdType="pubmed">34395821</ArticleId></ArticleIdList></Reference><Reference><Citation>Chandra R, Jain A, Singh Chauhan D. Deep learning via LSTM models for COVID-19 infection forecasting in India. PLoS ONE. (2022) 17:e0262708. 10.1371/journal.pone.0262708</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0262708</ArticleId><ArticleId IdType="pmc">PMC8797257</ArticleId><ArticleId IdType="pubmed">35089976</ArticleId></ArticleIdList></Reference><Reference><Citation>Lalmuanawma S, Hussain J, Chhakchhuak L. Applications of machine learning and artificial intelligence for Covid-19 (SARS-CoV-2) pandemic: a review. Chaos Solitons Fractals. (2020) 139:110059. 10.1016/j.chaos.2020.110059</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chaos.2020.110059</ArticleId><ArticleId IdType="pmc">PMC7315944</ArticleId><ArticleId IdType="pubmed">32834612</ArticleId></ArticleIdList></Reference><Reference><Citation>Zoabi Y, Deri-Rozov S, Shomron N. Machine learning-based prediction of COVID-19 diagnosis based on symptoms. npj Digit Med. (2021) 4:1&#x2013;5. 10.1038/s41746-020-00372-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41746-020-00372-6</ArticleId><ArticleId IdType="pmc">PMC7782717</ArticleId><ArticleId IdType="pubmed">33398013</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao L, Lediju Bell MA. A review of deep learning applications in lung ultrasound imaging of COVID-19 patients. BME Front. (2022) 2022:9780173. 10.34133/2022/9780173</Citation><ArticleIdList><ArticleId IdType="doi">10.34133/2022/9780173</ArticleId><ArticleId IdType="pmc">PMC9880989</ArticleId><ArticleId IdType="pubmed">36714302</ArticleId></ArticleIdList></Reference><Reference><Citation>Dang T, Han J, Xia T, Spathis D, Bondareva E, Siegele-Brown C, et al. . Exploring longitudinal cough, breath, and voice data for COVID-19 progression prediction via sequential deep learning: model development and validation. J Med Internet Res. (2022) 24:e37004. 10.2196/37004</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/37004</ArticleId><ArticleId IdType="pmc">PMC9217153</ArticleId><ArticleId IdType="pubmed">35653606</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin W, Dong S, Dong C, Ye X. Hybrid ensemble model for differential diagnosis between COVID-19 and common viral pneumonia by chest X-ray radiograph. Comput Biol Med. (2021) 131:104252. 10.1016/j.compbiomed.2021.104252</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.compbiomed.2021.104252</ArticleId><ArticleId IdType="pmc">PMC7966819</ArticleId><ArticleId IdType="pubmed">33610001</ArticleId></ArticleIdList></Reference><Reference><Citation>Soares E, Angelov P, Biaso S, Froes MH, Abe DK. SARS-CoV-2 CT-scan dataset: a large dataset of real patients CT scans for SARS-CoV-2 identification. MedRxiv. (2020). 10.1101/2020.04.24.20078584</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.04.24.20078584</ArticleId></ArticleIdList></Reference><Reference><Citation>Abadi M, Barham P, Chen J, Chen Z, Davis A, Dean J, et al. . TensorFlow: a system for Large-Scale machine learning. In: 12th USENIX Symposium on Operating Systems Design Implementation (OSDI 16). (2016). p. 265&#x2013;83. Available online at: https://www.usenix.org/system/files/conference/osdi16/osdi16-abadi.pdf</Citation></Reference><Reference><Citation>Alafif T, Tehame AM, Bajaba S, Barnawi A, Zia S. Machine and deep learning towards COVID-19 diagnosis and treatment: survey, challenges, and future directions. Int J Environ Res Public Health. (2021) 18:1117. 10.3390/ijerph18031117</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph18031117</ArticleId><ArticleId IdType="pmc">PMC7908539</ArticleId><ArticleId IdType="pubmed">33513984</ArticleId></ArticleIdList></Reference><Reference><Citation>Lv H, Shi L, Berkenpas JW, Dao FY, Zulfiqar H, Ding H, et al. . Application of artificial intelligence and machine learning for COVID-19 drug discovery and vaccine design. Brief Bioinform. (2021) 22:bbab320. 10.1093/bib/bbab320</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bib/bbab320</ArticleId><ArticleId IdType="pmc">PMC8511807</ArticleId><ArticleId IdType="pubmed">34410360</ArticleId></ArticleIdList></Reference><Reference><Citation>Law JN, Akers K, Tasnina N, Della Santina CM, Kshirsagar M, Klein-Seetharaman J, et al. . Identifying human interactors of SARS-CoV-2 proteins and drug targets for COVID-19 using network-based label propagation. arXiv preprint arXiv:200601968. (2020).</Citation></Reference><Reference><Citation>Ray S, Lall S, Bandyopadhyay S. A deep integrated framework for predicting SARS-CoV2-human protein-protein interaction. IEEE Trans Emerg Top Comput Intell. (2022) 6:1463&#x2013;72. 10.1109/TETCI.2022.3182354</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/TETCI.2022.3182354</ArticleId></ArticleIdList></Reference><Reference><Citation>Du BX, Qin Y, Jiang YF, Xu Y, Yiu SM, Yu H, et al. . Compound-protein interaction prediction by deep learning: databases, descriptors and models. Drug Discov Today. (2022) 27:1350&#x2013;66. 10.1016/j.drudis.2022.02.023</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.drudis.2022.02.023</ArticleId><ArticleId IdType="pubmed">35248748</ArticleId></ArticleIdList></Reference><Reference><Citation>Mylonas SK, Axenopoulos A, Daras P. DeepSurf: a surface-based deep learning approach for the prediction of ligand binding sites on proteins. Bioinformatics. (2021) 37:1681&#x2013;90. 10.1093/bioinformatics/btab009</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btab009</ArticleId><ArticleId IdType="pubmed">33471069</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q, Wang PS, Zhu C, Gaines BB, Zhu T, Bi J, et al. . OctSurf: efficient hierarchical voxel-based molecular surface representation for protein-ligand affinity prediction. J Mol Graphics Model. (2021) 105:107865. 10.1016/j.jmgm.2021.107865</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmgm.2021.107865</ArticleId><ArticleId IdType="pubmed">33640787</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones D, Kim H, Zhang X, Zemla A, Stevenson G, Bennett WD, et al. . Improved protein-ligand binding affinity prediction with structure-based deep fusion inference. J Chem Inf Model. (2021) 61:1583&#x2013;92. 10.1021/acs.jcim.0c01306</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jcim.0c01306</ArticleId><ArticleId IdType="pubmed">33754707</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng Z, Chen M, Liang T, Shen M, Chen H, Xie XQ. Virus-CKB: an integrated bioinformatics platform and analysis resource for COVID-19 research. Brief Bioinform. (2021) 22:882&#x2013;95. 10.1093/bib/bbaa155</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bib/bbaa155</ArticleId><ArticleId IdType="pmc">PMC7454273</ArticleId><ArticleId IdType="pubmed">32715315</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhavoronkov A, Aladinskiy V, Zhebrak A, Zagribelnyy B, Terentiev V, Bezrukov D, et al. . Potential COVID-2019 3C-like protease inhibitors designed using generative deep learning approaches. ChemRxiv. Preprint. (2020) 11:102. 10.26434/chemrxiv.11829102</Citation><ArticleIdList><ArticleId IdType="doi">10.26434/chemrxiv.11829102</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang B, He F, Liu D, He F, Wu T, Fang M, et al. . AI-aided design of novel targeted covalent inhibitors against SARS-CoV-2. Biomolecules. (2022) 12:746. 10.3390/biom12060746</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom12060746</ArticleId><ArticleId IdType="pmc">PMC9220321</ArticleId><ArticleId IdType="pubmed">35740872</ArticleId></ArticleIdList></Reference><Reference><Citation>Ton AT, Gentile F, Hsing M, Ban F, Cherkasov A. Rapid identification of potential inhibitors of SARS-CoV-2 main protease by deep docking of 1.3 billion compounds. Mol Inform. (2020) 39:2000028. 10.1002/minf.202000028</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/minf.202000028</ArticleId><ArticleId IdType="pmc">PMC7228259</ArticleId><ArticleId IdType="pubmed">32162456</ArticleId></ArticleIdList></Reference><Reference><Citation>Srinivasan S, Batra R, Chan H, Kamath G, Cherukara MJ, Sankaranarayanan SK. Artificial intelligence-guided De novo molecular design targeting COVID-19. ACS Omega. (2021) 6:12557&#x2013;66. 10.1021/acsomega.1c00477</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsomega.1c00477</ArticleId><ArticleId IdType="pmc">PMC8154149</ArticleId><ArticleId IdType="pubmed">34056406</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z, Liu M, Luo Y, Xu Z, Xie Y, Wang L, et al. . Advanced graph and sequence neural networks for molecular property prediction and drug discovery. Bioinformatics. (2022) 38:2579&#x2013;86. 10.1093/bioinformatics/btac112</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btac112</ArticleId><ArticleId IdType="pubmed">35179547</ArticleId></ArticleIdList></Reference><Reference><Citation>Medina-Ortiz D, Contreras S, Amado-Hinojosa J, Torres-Almonacid J, Asenjo JA, Navarrete M, et al. . Generalized property-based encoders and digital signal processing facilitate predictive tasks in protein engineering. Front Mol Biosci. (2022) 9:898627. 10.3389/fmolb.2022.898627</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmolb.2022.898627</ArticleId><ArticleId IdType="pmc">PMC9329607</ArticleId><ArticleId IdType="pubmed">35911960</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferruz N, H&#xf6;cker B. Controllable protein design with language models. Nat Mach Intell. (2022) 4:521&#x2013;32. 10.1038/s42256-022-00499-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42256-022-00499-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Wigh DS, Goodman JM, Lapkin AA. A review of molecular representation in the age of machine learning. Wiley Interdisc Rev Comput Mol Sci. (2022) 12:e1603. 10.1002/wcms.1603</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/wcms.1603</ArticleId><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Verkuil R, Kabeli O, Du Y, Wicky BI, Milles LF, Dauparas J, et al. . Language models generalize beyond natural proteins. bioRxiv. (2022) 10.1101/2022.12.21.521521</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.12.21.521521</ArticleId></ArticleIdList></Reference><Reference><Citation>Minh D, Wang HX, Li YF, Nguyen TN. Explainable artificial intelligence: a comprehensive review. Artif Intell Rev. (2022) 55:3503&#x2013;68. 10.1007/s10462-021-10088-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10462-021-10088-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen CC, Chang CK, Chiu CC, Yang TY, Hao WR, Lin CH, et al. . Machine learning analyses revealed distinct arterial pulse variability according to side effects of Pfizer-BioNTech COVID-19 vaccine (BNT162b2). J Clin Med. (2022) 11:6119. 10.3390/jcm11206119</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11206119</ArticleId><ArticleId IdType="pmc">PMC9605457</ArticleId><ArticleId IdType="pubmed">36294440</ArticleId></ArticleIdList></Reference><Reference><Citation>Abbaspour S, Robbins GK, Blumenthal KG, Hashimoto D, Hopcia K, Mukerji SS, et al. . Identifying modifiable predictors of COVID-19 vaccine side effects: a machine learning approach. Vaccines. (2022) 10:1747. 10.3390/vaccines10101747</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10101747</ArticleId><ArticleId IdType="pmc">PMC9608090</ArticleId><ArticleId IdType="pubmed">36298612</ArticleId></ArticleIdList></Reference><Reference><Citation>Flora J, Khan W, Jin J, Jin D, Hussain A, Dajani K, et al. . Usefulness of vaccine adverse event reporting system for machine-learning based vaccine research: A Case study for COVID-19 vaccines. Int J Mol Sci. (2022) 23:8235. 10.3390/ijms23158235</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23158235</ArticleId><ArticleId IdType="pmc">PMC9368306</ArticleId><ArticleId IdType="pubmed">35897804</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta M, Jain R, Taneja S, Chaudhary G, Khari M, Verd&#xfa; E. Real-time measurement of the uncertain epidemiological appearances of COVID-19 infections. Appl Soft Comput. (2021) 101:107039. 10.1016/j.asoc.2020.107039</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.asoc.2020.107039</ArticleId><ArticleId IdType="pmc">PMC7833666</ArticleId><ArticleId IdType="pubmed">33519324</ArticleId></ArticleIdList></Reference><Reference><Citation>Mansour RF, Escorcia-Gutierrez J, Gamarra M, Gupta D, Castillo O, Kumar S. Unsupervised deep learning based variational autoencoder model for COVID-19 diagnosis and classification. Pattern Recogn Lett. (2021) 151:267&#x2013;74. 10.1016/j.patrec.2021.08.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.patrec.2021.08.018</ArticleId><ArticleId IdType="pmc">PMC8455283</ArticleId><ArticleId IdType="pubmed">34566223</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang D, Zuo F, Gao J, He Y, Bian Z, Bernardes SD, et al. . Agent-based simulation model and deep learning techniques to evaluate and predict transportation trends around COVID-19. arXiv preprint arXiv:201009648. (2020). 10.48550/arXiv.2010.09648</Citation><ArticleIdList><ArticleId IdType="doi">10.48550/arXiv.2010.09648</ArticleId></ArticleIdList></Reference><Reference><Citation>Kompella V, Capobianco R, Jong S, Browne J, Fox S, Meyers L, et al. . Reinforcement learning for optimization of COVID-19 mitigation policies. arXiv preprint arXiv:201010560. (2020). 10.48550/arXiv.2010.10560</Citation><ArticleIdList><ArticleId IdType="doi">10.48550/arXiv.2010.10560</ArticleId></ArticleIdList></Reference><Reference><Citation>Medina-Ortiz D, Contreras S, Barrera-Saavedra Y, Cabas-Mora G, Olivera-Nappa &#xc1;. Country-wise forecast model for the effective reproduction number R t of coronavirus disease. Front Phys. (2020) 8:304. 10.3389/fphy.2020.00304</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphy.2020.00304</ArticleId></ArticleIdList></Reference><Reference><Citation>Contreras S, Villavicencio HA, Medina-Ortiz D, Saavedra CP, Olivera-Nappa &#xc1;. Real-time estimation of R t for supporting public-health policies against COVID-19. Front Public Health. (2020). 8:556689. 10.3389/fpubh.2020.556689</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2020.556689</ArticleId><ArticleId IdType="pmc">PMC7783316</ArticleId><ArticleId IdType="pubmed">33415091</ArticleId></ArticleIdList></Reference><Reference><Citation>Polyzos S, Samitas A, Spyridou AE. Tourism demand and the COVID-19 pandemic: an LSTM approach. Tour Recreat Res. (2021) 46:175&#x2013;87. 10.1080/02508281.2020.1777053</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/02508281.2020.1777053</ArticleId><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Hills S, Eraso Y. Factors associated with non-adherence to social distancing rules during the COVID-19 pandemic: a logistic regression analysis. BMC Public Health. (2021) 21:1&#x2013;25. 10.1186/s12889-021-10379-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-021-10379-7</ArticleId><ArticleId IdType="pmc">PMC7881344</ArticleId><ArticleId IdType="pubmed">33581734</ArticleId></ArticleIdList></Reference><Reference><Citation>Saba AI, Elsheikh AH. Forecasting the prevalence of COVID-19 outbreak in Egypt using nonlinear autoregressive artificial neural networks. Process Safety Environ Protect. (2020) 141:1&#x2013;8. 10.1016/j.psep.2020.05.029</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psep.2020.05.029</ArticleId><ArticleId IdType="pmc">PMC7237379</ArticleId><ArticleId IdType="pubmed">32501368</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh RK, Rani M, Bhagavathula AS, Sah R, Rodriguez-Morales AJ, Kalita H, et al. . Prediction of the COVID-19 pandemic for the top 15 affected countries: Advanced autoregressive integrated moving average (ARIMA) model. JMIR Public Health Surveill. (2020) 6:e19115. 10.2196/19115</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/19115</ArticleId><ArticleId IdType="pmc">PMC7223426</ArticleId><ArticleId IdType="pubmed">32391801</ArticleId></ArticleIdList></Reference><Reference><Citation>Ketu S, Mishra PK. Enhanced Gaussian process regression-based forecasting model for COVID-19 outbreak and significance of IoT for its detection. Appl Intell. (2021) 51:1492&#x2013;512. 10.1007/s10489-020-01889-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10489-020-01889-9</ArticleId><ArticleId IdType="pmc">PMC7785924</ArticleId><ArticleId IdType="pubmed">34764576</ArticleId></ArticleIdList></Reference><Reference><Citation>Castillo Ossa LF, Chamoso P, Arango-L&#xf3;pez J, Pinto-Santos F, Isaza GA, Santa-Cruz-Gonz&#xe1;lez C, et al. . A hybrid model for COVID-19 monitoring and prediction. Electronics. (2021) 10:799. 10.3390/electronics10070799</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/electronics10070799</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng FY, Joshi H, Tandon P, Freeman R, Reich DL, Mazumdar M, et al. . Using machine learning to predict ICU transfer in hospitalized COVID-19 patients. J Clin Med. (2020) 9:1668. 10.3390/jcm9061668</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9061668</ArticleId><ArticleId IdType="pmc">PMC7356638</ArticleId><ArticleId IdType="pubmed">32492874</ArticleId></ArticleIdList></Reference><Reference><Citation>Alamrouni A, Aslanova F, Mati S, Maccido HS, Jibril AA, Usman A, et al. . Multi-regional modeling of cumulative COVID-19 cases integrated with environmental forest knowledge estimation: a deep learning ensemble approach. Int J Environ Res Public Health. (2022) 19:738. 10.3390/ijerph19020738</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph19020738</ArticleId><ArticleId IdType="pmc">PMC8775387</ArticleId><ArticleId IdType="pubmed">35055559</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfaff ER, Girvin AT, Bennett TD, Bhatia A, Brooks IM, Deer RR, et al. . Identifying who has long COVID in the USA: a machine learning approach using N3C data. Lancet Digit Health. (2022) 4:e532&#x2013;41. 10.1016/S2589-7500(22)00048-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2589-7500(22)00048-6</ArticleId><ArticleId IdType="pmc">PMC9110014</ArticleId><ArticleId IdType="pubmed">35589549</ArticleId></ArticleIdList></Reference><Reference><Citation>Binka M, Klaver B, Cua G, Wong AW, Fibke C, Vel&#xe1;squez Garc&#xed;a HA, et al. . An elastic net regression model for identifying long COVID patients using health administrative data: a population-based study. In: Open Forum Infectious Diseases. vol. 9. Oxford: Oxford University Press US; (2022). p. ofac640.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9780702</ArticleId><ArticleId IdType="pubmed">36570972</ArticleId></ArticleIdList></Reference><Reference><Citation>Fritsche LG, Jin W, Admon AJ, Mukherjee B. Characterizing and predicting post-acute sequelae of SARS CoV-2 infection (PASC) in a large academic medical center in the US. medRxiv. (2022) 10.1101/2022.10.21.22281356</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.10.21.22281356</ArticleId><ArticleId IdType="pmc">PMC9967320</ArticleId><ArticleId IdType="pubmed">36835863</ArticleId></ArticleIdList></Reference><Reference><Citation>Sengupta S, Loomba J, Sharma S, Brown DE, Thorpe L, Haendel MA, et al. . Analyzing historical diagnosis code data from NIH N3C and RECOVER Programs using deep learning to determine risk factors for Long COVID. arXiv preprint arXiv:221002490. (2022) 10.1109/BIBM55620.2022.9994851</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/BIBM55620.2022.9994851</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta A, Jain V, Singh A. Stacking ensemble-based intelligent machine learning model for predicting post-COVID-19 complications. N Generat Comput. (2022) 40:987&#x2013;1007. 10.1007/s00354-021-00144-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00354-021-00144-0</ArticleId><ArticleId IdType="pmc">PMC8669670</ArticleId><ArticleId IdType="pubmed">34924675</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>